Kirkland Advises R1 RCM on Cloudmed Acquisition
Kirkland & Ellis advised R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, which today announced that it has entered into a definitive agreement to acquire Cloudmed, a leader in Revenue Intelligence™ solutions for healthcare providers, in an all-stock transaction. The transaction values Cloudmed at approximately $4.1 billion, including $857 million of net debt, based on R1’s closing stock price on January 7, 2022. The transaction, which has been unanimously approved by the boards of directors of both companies, is expected to close in the second quarter of 2022, subject to approvals and closing conditions.
Read more in R1’s press release
The Kirkland team was led by corporate partners Bradley Reed and Richard Porter with corporate associates Will Lawley, Jonathan Slack and Ian Hesterly, capital markets partners Robert Hayward and Alexander Schwartz and associates Ben Richards and Nick Pappas, debt finance partners Louis Hernandez and John Kefer, and tax partners Rachel Cantor and Polina Liberman and associate Nicholas Warther.
